Unknown

Dataset Information

0

Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors.

ABSTRACT: A series of novel benzohydrazide derivatives containing dihydropyrazoles have been synthesized as potential epidermal growth factor receptor (EGFR) kinase inhibitors and their biological activities as potential antiproliferative agents have been evaluated. Among these compounds, compound H20 exhibited the most potent antiproliferative activity against four cancer cell line variants (A549, MCF-7, HeLa, HepG2) with IC50 values of 0.46, 0.29, 0.15 and 0.21 ?M respectively, which showed the most potent EGFR inhibition activities (IC50 = 0.08 ?M for EGFR). Molecular modeling simulation studies were performed in order to predict the biological activity and activity relationship (SAR) of these benzohydrazide derivatives. These results suggested that compound H20 may be a promising anticancer agent.

SUBMITTER: Wang HC 

PROVIDER: S-EPMC6273578 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors.

Wang Hai-Chao HC   Yan Xiao-Qiang XQ   Yan Tian-Long TL   Li Hong-Xia HX   Wang Zhong-Chang ZC   Zhu Hai-Liang HL  

Molecules (Basel, Switzerland) 20160803 8

A series of novel benzohydrazide derivatives containing dihydropyrazoles have been synthesized as potential epidermal growth factor receptor (EGFR) kinase inhibitors and their biological activities as potential antiproliferative agents have been evaluated. Among these compounds, compound H20 exhibited the most potent antiproliferative activity against four cancer cell line variants (A549, MCF-7, HeLa, HepG2) with IC50 values of 0.46, 0.29, 0.15 and 0.21 μM respectively, which showed the most pot  ...[more]

Similar Datasets

Unknown Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors.
| S-EPMC5715404 | biostudies-literature
Unknown New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
| S-EPMC7914722 | biostudies-literature
Unknown Design, synthesis and <i>in vitro</i> biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment.
| S-EPMC7006757 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR.
| S-EPMC4027470 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3K? Inhibitors.
| S-EPMC6804295 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
| S-EPMC7144934 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors.
| S-EPMC6983042 | biostudies-literature
Unknown Design, synthesis and biological evaluation of novel 2-phenyl pyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.
| S-EPMC6390688 | biostudies-literature
Unknown Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors.
| S-EPMC4406240 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3K? Inhibitors.
| S-EPMC6274018 | biostudies-literature